Results 41 to 50 of about 21,988 (154)

Notes from the field: The Inflation Reduction Act and Enbrel

Arthritis &Rheumatology, Accepted Article.
Charles L Bennett, Jason B Gibbons, Chadi Nabhan, Kenneth R Carson, June M McKoy, Kevin B Knopf, Gerald Anderson   +6 more
wiley   +1 more source

Malignancies and immunoglobulin G4‐related disease

Rheumatology &Autoimmunity, EarlyView.
Immunoglobulin G4‐related disease (IgG4‐RD) is associated with increased cancer risk. Malignancies affect both IgG4‐RD involved organs, such as the lung, pancreas, bile duct, and prostate, and noninvolved organs, such as the gastrointestinal duct. B‐cell neoplasms constitute a proportion of the malignancies linked to this disease.
Jingna Li, Wen Zhang
wiley   +1 more source

Artificial intelligence in rheumatoid arthritis

Rheumatology &Autoimmunity, EarlyView.
Advancements in artificial intelligence (AI) over the past 5 years have brought significant progress to the medical field, including rheumatoid arthritis (RA). AI integrates multimodal data, including clinical, imaging, omics, and longitudinal information, to enhance RA diagnosis and treatment.
Yiduo Sun, Jin Lin, Weiqian Chen
wiley   +1 more source

Gastrointestinal Perforations Associated With JAK Inhibitors: A Disproportionality Analysis of the FDA Adverse Event Reporting System

United European Gastroenterology Journal, EarlyView.
ABSTRACT Background Gastrointestinal perforations have been reported in a small number of rheumatoid arthritis (RA) patients treated with Janus kinase (JAK) inhibitors in clinical trials. However, large‐scale postmarketing data repositories are needed to further investigate this potentially rare but serious adverse event.
Adam Goldman, Emanuel Raschi, Amit Druyan, Kassem Sharif, Adi Lahat, Ilan Ben‐Zvi, Shomron Ben‐Horin   +6 more
wiley   +1 more source

OpenSAFELY: The impact of COVID‐19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate

British Journal of Clinical Pharmacology, EarlyView.
Aims The COVID‐19 pandemic created unprecedented pressure on healthcare services. This study investigates whether disease‐modifying antirheumatic drug (DMARD) safety monitoring was affected during the COVID‐19 pandemic. Methods A population‐based cohort study was conducted using the OpenSAFELY platform to access electronic health record data from 24.2 ...
Andrew D. Brown, Louis Fisher, Helen J. Curtis, Milan Wiedemann, William J. Hulme, Victoria Speed, Lisa E. M. Hopcroft, Christine Cunningham, Ruth E. Costello, James B. Galloway, Mark D. Russell, Katie Bechman, Zeyneb Kurt, Richard Croker, Chris Wood, Alex J. Walker, Andrea L. Schaffer, Seb C. J. Bacon, Amir Mehrkar, George Hickman, Chris Bates, Jonathan Cockburn, John Parry, Frank Hester, Sam Harper, Ben Goldacre, The OpenSAFELY Collaborative, Brian MacKenna   +27 more
wiley   +1 more source

Social media as a source of drug safety information in the paediatric population

British Journal of Clinical Pharmacology, EarlyView.
Aims The paediatric population is vulnerable to suffering adverse drug events (ADEs) such as negative outcomes due to medication (NOMs)–drug related problems (DRPs), especially adverse drug reactions (ADRs) and medication errors (MEs). Social media (SM) is considered an interesting tool for pharmacovigilance.
Ingrid Vilimelis‐Piulats, Ariadna Pérez‐Ricart, Maite Bosch Peligero, Albert Calvo, Josep Maria Suñé Negre, Juan‐Carlos Juárez‐Gimenez   +5 more
wiley   +1 more source

Dental Implant Therapy in Patients With Autoimmune Diseases: A Scoping Review

Clinical Oral Implants Research, EarlyView.
ABSTRACT Objectives The aim of this scoping review is to determine the effects of autoimmune diseases (ADs) and the agents used for treatment on dental implant survival and biologic outcomes. Material and Methods An electronic database search was performed in MEDLINE (PubMed), The Cochrane Library, and Embase on 29‐04‐2024.
Emil Hyldahl, Henning Schliephake, Simon Storgård Jensen   +2 more
wiley   +1 more source

Clinical characteristics and treatment of varicella zoster virus central nervous system infection in an Australian tertiary hospital

Internal Medicine Journal, EarlyView.
Abstract Background and Aim Varicella zoster virus (VZV) is a neurotropic herpesvirus. With improved access to molecular diagnostics, there is increasing recognition of VZV with central nervous system involvement. This study aimed to describe the demographic, clinical and treatment characteristics of patients admitted to an Australian tertiary hospital
Connie Lam, Eve Chen, Arthur Thevathasan, Terry Yan, Michael Moso, Joe Sasadeusz, Stephen Muhi   +6 more
wiley   +1 more source

A case of visceral leishmaniasis mimicking connective tissue disease

Rheumatology &Autoimmunity, EarlyView.
Yucui Li, Hongxia Yang, Tingzi Zhao, Ke Xu, Liyun Zhang   +4 more
wiley   +1 more source

Hidradenitis suppurativa with and without draining tunnels: A real‐world study characterizing differences in treatment and disease burden

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This real‐world study found that patients with moderate–severe hidradenitis suppurativa (HS) and draining tunnels experienced a greater clinical and health‐related quality of life burden compared with patients without draining tunnels. This study indicates that more effective treatments are needed for patients with moderate–severe HS with draining ...
J. R. Ingram, A. V. Marzano, E. Prens, S. Schneider‐Burrus, R. B. Warren, A. Keal, R. Jha, A. C. Hernandez Daly, A. B. Kimball   +8 more
wiley   +1 more source